Rapid Micro Biosystems (NASDAQ:RPID) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02), Zacks reports. Rapid Micro Biosystems had a negative net margin of 145.56% and a negative return on equity of 177.04%.

Rapid Micro Biosystems Price Performance

NASDAQ:RPID traded up $0.08 during mid-day trading on Monday, hitting $0.73. The company’s stock had a trading volume of 2,626,310 shares, compared to its average volume of 230,674. The company has a market capitalization of $36.82 million, a price-to-earnings ratio of -0.66 and a beta of 1.52. The company has a current ratio of 2.55, a quick ratio of 1.51 and a debt-to-equity ratio of 1.08. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $4.94. The stock has a fifty day moving average of $0.92 and a 200-day moving average of $2.08.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Roth Capital started coverage on Rapid Micro Biosystems in a research report on Tuesday, September 29th. They issued a “buy” rating and a $3.00 target price for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $5.00.

Get Our Latest Stock Analysis on Rapid Micro Biosystems

Rapid Micro Biosystems Company Profile

(Get Free Report)

Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.

Featured Articles

Earnings History for Rapid Micro Biosystems (NASDAQ:RPID)

Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.